南模生物
(688265)
| 流通市值：12.29亿 | | | 总市值：19.40亿 |
| 流通股本：4938.85万 | | | 总股本：7796.35万 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 99,888,190.2 | 159,348,571.26 | 358,711,958.77 | 368,032,631.5 |
| 应收票据及应收账款 | 137,034,988.34 | 127,583,206.77 | 138,422,312.72 | 92,636,686.51 |
| 应收账款 | 137,034,988.34 | 127,583,206.77 | 138,422,312.72 | 92,636,686.51 |
| 预付款项 | 1,568,245.38 | 2,221,530.23 | 8,872,115.16 | 2,519,883.07 |
| 其他应收款合计 | 5,740,076.69 | 5,904,119.55 | 7,297,516.22 | 6,644,749.46 |
| 存货 | 17,050,017.53 | 15,512,204.85 | 15,644,715.6 | 17,102,400.13 |
| 其他流动资产 | 8,598,256.48 | 10,129,790.85 | 10,622,858.71 | 10,993,392.62 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,192,059,837.78 | 1,205,683,610.51 | 1,238,452,032.74 | 1,260,656,573.26 |
| 非流动资产: | | | | |
| 其他权益工具投资 | - | - | 20,000,000 | - |
| 其他非流动金融资产 | 51,000,000 | 51,000,000 | 100,119,444.44 | 100,094,444.44 |
| 固定资产 | 151,746,392.3 | 126,953,766.39 | 118,640,906.99 | 119,807,372.24 |
| 在建工程 | 184,206,635.45 | 194,589,624.31 | 161,878,177.25 | 155,244,907.3 |
| 使用权资产 | 81,474,251.02 | 87,011,211.51 | 86,435,828.57 | 91,732,466.78 |
| 无形资产 | 240,259,518.24 | 241,809,351.9 | 243,325,858.13 | 244,872,914.52 |
| 长期待摊费用 | 79,245,732.77 | 83,648,073.52 | 61,688,801.93 | 65,096,478.64 |
| 递延所得税资产 | 16,179,638.45 | 15,198,663.39 | 13,453,162.63 | 11,537,363.02 |
| 其他非流动资产 | 9,928,808.63 | 9,062,193.8 | 9,206,867 | 4,635,445.32 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 814,040,976.86 | 809,272,884.82 | 814,749,046.94 | 793,021,392.26 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,006,100,814.64 | 2,014,956,495.33 | 2,053,201,079.68 | 2,053,677,965.52 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 26,956,281.74 | 27,869,794.42 | 30,128,351.62 | 26,828,510.93 |
| 应付账款 | 26,956,281.74 | 27,869,794.42 | 30,128,351.62 | 26,828,510.93 |
| 合同负债 | 94,939,007.37 | 85,647,910.56 | 110,846,033.47 | 88,394,235.02 |
| 应付职工薪酬 | 17,797,974.66 | 19,710,411.85 | 13,634,758.38 | 25,238,907.65 |
| 应交税费 | 1,612,981.82 | 950,095.81 | 1,805,454.9 | 1,622,328.36 |
| 其他应付款合计 | 11,184,568.84 | 11,537,689.77 | 9,650,999.99 | 12,980,558.24 |
| 一年内到期的非流动负债 | 21,586,350.11 | 25,414,932.84 | 13,700,000 | 13,686,190 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 174,077,164.54 | 171,130,835.25 | 179,765,598.36 | 168,750,730.2 |
| 非流动负债: | | | | |
| 长期借款 | - | - | 11,500,000 | 11,550,000 |
| 租赁负债 | 66,284,953.33 | 68,575,849.1 | 94,424,954.56 | 95,711,020.97 |
| 递延收益 | 9,957,110.1 | 10,408,748.31 | 10,958,693.35 | 11,348,802.11 |
| 递延所得税负债 | 383,607.6 | 389,347.92 | 231,382.23 | 390,581.42 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 76,625,671.03 | 79,373,945.33 | 117,115,030.14 | 119,000,404.5 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 250,702,835.57 | 250,504,780.58 | 296,880,628.5 | 287,751,134.7 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 77,963,513 | 77,963,513 | 77,963,513 | 77,963,513 |
| 资本公积 | 1,565,858,839.31 | 1,563,267,526.78 | 1,567,283,763.38 | 1,562,586,800.31 |
| 其他综合收益 | 676,217.3 | 613,219.15 | -206,358.94 | -134,635.78 |
| 盈余公积 | 16,456,620.2 | 16,456,620.2 | 16,456,620.2 | 16,456,620.2 |
| 未分配利润 | 94,442,789.26 | 106,150,835.62 | 94,822,913.54 | 109,054,533.09 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,755,397,979.07 | 1,764,451,714.75 | 1,756,320,451.18 | 1,765,926,830.82 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,755,397,979.07 | 1,764,451,714.75 | 1,756,320,451.18 | 1,765,926,830.82 |
| 负债和股东权益合计 | 2,006,100,814.64 | 2,014,956,495.33 | 2,053,201,079.68 | 2,053,677,965.52 |
| 公告日期 | 2023-10-31 | 2023-08-31 | 2023-04-28 | 2023-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |